WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
+$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$152M |
| 3 |
Brown & Brown
BRO
|
+$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$113M |
| 5 |
Akero Therapeutics
AKRO
|
+$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
EyePoint Pharmaceuticals
EYPT
$941M
| $4.71M | 0.02% |
500,335
| – | – |
|
577
Idexx Laboratories
IDXX
$52.2B
| $4.67M | 0.02% |
+8,699
| New | +$4.67M |
|
578
Kimberly-Clark
KMB
$43.1B
| $4.63M | 0.02% |
+35,892
| New | +$4.63M |
|
579
Fidelity National Information Services
FIS
$36B
| $4.63M | 0.02% |
56,832
+54,064
| +1,953% | +$4.4M |
|
|
BRDG
580
DELISTED
Bridge Investment Group
BRDG
| $4.6M | 0.02% |
460,000
+21,948
| +5% | +$220K |
|
581
Reinsurance Group of America
RGA
$12.7B
| $4.56M | 0.02% |
22,987
-145,488
| -86% | -$28.9M |
|
582
Valero Energy
VLO
$48.9B
| $4.55M | 0.02% |
33,879
+7,132
| +27% | +$959K |
|
583
Public Service Enterprise Group
PEG
$40B
| $4.54M | 0.02% |
53,976
+11,883
| +28% | +$1M |
|
584
Xoma
XOMA
$427M
| $4.54M | 0.02% |
180,230
+11,680
| +7% | +$294K |
|
585
Ross Stores
ROST
$49.6B
| $4.54M | 0.02% |
35,569
+7,694
| +28% | +$982K |
|
586
Eledon Pharmaceuticals
ELDN
$154M
| $4.53M | 0.02% |
1,671,822
| – | – |
|
587
CBRE Group
CBRE
$48.7B
| $4.45M | 0.02% |
31,764
+6,792
| +27% | +$952K |
|
|
ORKA
588
Oruka Therapeutics, Inc. Common Stock
ORKA
$592M
| $4.38M | 0.02% |
390,904
+100
| +0% | +$1.12K |
|
589
Riot Platforms
RIOT
$4.97B
| $4.36M | 0.02% |
385,565
-423,209
| -52% | -$4.78M |
|
590
Surmodics
SRDX
$471M
| $4.31M | 0.02% |
+144,977
| New | +$4.31M |
|
591
Forte Biosciences
FBRX
$138M
| $4.29M | 0.02% |
331,987
+127,165
| +62% | +$1.64M |
|
592
Xcel Energy
XEL
$42.4B
| $4.25M | 0.02% |
62,387
+13,872
| +29% | +$945K |
|
593
Dave & Buster's
PLAY
$805M
| $4.25M | 0.02% |
141,162
-18,494
| -12% | -$556K |
|
594
Aurinia Pharmaceuticals
AUPH
$1.62B
| $4.24M | 0.02% |
500,416
| – | – |
|
595
Biohaven
BHVN
$1.53B
| $4.24M | 0.02% |
300,389
-300,060
| -50% | -$4.23M |
|
596
Charter Communications
CHTR
$36B
| $4.22M | 0.02% |
+10,324
| New | +$4.22M |
|
597
UroGen Pharma
URGN
$991M
| $4.2M | 0.02% |
306,724
+353
| +0.1% | +$4.84K |
|
598
Humacyte
HUMA
$223M
| $4.18M | 0.02% |
2,001,393
-1,948,607
| -49% | -$4.07M |
|
599
Devon Energy
DVN
$21.9B
| $4.13M | 0.02% |
129,733
+13,953
| +12% | +$444K |
|
600
Baker Hughes
BKR
$45B
| $4.11M | 0.02% |
107,168
+23,518
| +28% | +$902K |
|